Zangerle John Adam
SEC CIK 1578804 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| STE | Steris | SVP, Gen Counsel, Sec | 35.3K | — | $7.34M | 31 | 2021-10-01 | 2026-06-15 |
Most active insiders at STE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Zangerle John Adam | SVP, Gen Counsel, Sec | — | $4.27M |
| 2 | Madsen Julia | SVP, GM, Life Sciences | — | $1.31M |
| 3 | Tamaro Renato | VP, Corp. Treas | — | $1.30M |
| 4 | Carestio Daniel A | Pres, CEO, Dir | — | $985.2K |
| 5 | Sohi Mohsen | Dir | — | $956.8K |
| 6 | FELDMANN CYNTHIA L | Dir | — | $734.9K |
| 7 | Breeden Richard C | Dir | — | $310.3K |
| 8 | McGowan Lindsey | VP, Chf. Comp, Quality Offc | — | — |
| 9 | Kohler Kenneth E | SVP, GM, AST | — | — |
| 10 | Fraser Mary Clare | SVP, Chief HRO | — | — |
Transactions 31
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-06-16 16:31 | 2026-06-15 | STE | Steris | Zangerle John Adam | SVP, Gen Counsel, Sec | S - Sale | $209.28 | -1,419 | 35.3K | -4% | -$297.0K |
| 2026-06-08 16:33 | 2026-06-04 | STE | Steris | Zangerle John Adam | SVP, Gen Counsel, Sec | F - Tax | $212.24 | -401 | 36.7K | -1% | -$85.1K | |
| 2026-06-05 16:33 | 2026-06-03 | STE | Steris | Zangerle John Adam | SVP, Gen Counsel, Sec | F - Tax | $210.19 | -365 | 37.1K | -1.0% | -$76.7K | |
| D | 2026-06-04 16:35 | 2026-06-02 | STE | Steris | Zangerle John Adam | SVP, Gen Counsel, Sec | A - Grant | $0.00 | +4,359 | 37.7K | +13% | $0 |
| D | 2026-06-04 16:35 | 2026-06-02 | STE | Steris | Zangerle John Adam | SVP, Gen Counsel, Sec | F - Tax | $209.76 | -247 | 37.4K | -0.7% | -$51.8K |
| 2026-06-03 16:42 | 2026-06-01 | STE | Steris | Zangerle John Adam | SVP, Gen Counsel, Sec | F - Tax | $0.00 | -337 | 33.3K | -1% | $0 | |
| D | 2025-11-13 | 2025-11-11 | STE | Steris | Zangerle John Adam | SVP, Gen Counsel, Sec | M - OptEx | $69.72 | +15.0K | 48.7K | +45% | +$1.05M |
| D | 2025-11-13 | 2025-11-11 | STE | Steris | Zangerle John Adam | SVP, Gen Counsel, Sec | S - Sale+OE | $265.14 | -15.0K | 33.7K | -31% | -$3.98M |
| 2025-10-03 | 2025-10-01 | STE | Steris | Zangerle John Adam | SVP, Gen Counsel, Sec | F - Tax | $0.00 | -91 | 33.7K | -0.3% | $0 | |
| M | 2025-06-17 | 2025-06-13 | STE | Steris | Zangerle John Adam | SVP, Gen Counsel, Sec | S - Sale | $241.45 | -1,978 | 35.4K | -5% | -$477.6K |
| 2025-06-06 | 2025-06-04 | STE | Steris | Zangerle John Adam | SVP, Gen Counsel, Sec | F - Tax | $242.10 | -425 | 35.7K | -1% | -$102.9K | |
| D | 2025-06-05 | 2025-06-03 | STE | Steris | Zangerle John Adam | SVP, Gen Counsel, Sec | A - Grant | $0.00 | +3,756 | 36.2K | +12% | $0 |
| M | 2025-06-04 | 2025-06-02 | STE | Steris | Zangerle John Adam | SVP, Gen Counsel, Sec | F - Tax | $242.08 | -844 | 32.4K | -3% | -$204.3K |
| 2024-10-02 | 2024-10-01 | STE | Steris | Zangerle John Adam | SVP, Gen Counsel, Sec | F - Tax | $235.78 | -91 | 33.3K | -0.3% | -$21.5K | |
| D | 2024-06-06 | 2024-06-04 | STE | Steris | Zangerle John Adam | SVP, Gen Counsel, Sec | A - Grant | $0.00 | +4,128 | 33.3K | +14% | $0 |
| M | 2024-06-05 | 2024-06-03 | STE | Steris | Zangerle John Adam | SVP, Gen Counsel, Sec | F - Tax | $228.37 | -723 | 29.2K | -2% | -$165.1K |
| 2024-06-04 | 2024-05-31 | STE | Steris | Zangerle John Adam | SVP, Gen Counsel, Sec | F - Tax | $222.88 | -346 | 29.9K | -1% | -$77.1K | |
| 2023-10-04 | 2023-10-02 | STE | Steris | Zangerle John Adam | SVP, Gen Counsel, Sec | F - Tax | $215.50 | -61 | 30.3K | -0.2% | -$13.1K | |
| 2023-06-06 | 2023-06-02 | STE | Steris | Zangerle John Adam | SVP, Gen Counsel, Sec | F - Tax | $205.47 | -498 | 30.3K | -2% | -$102.3K | |
| 2023-06-05 | 2023-06-01 | STE | Steris | Zangerle John Adam | SVP, Gen Counsel, Sec | F - Tax | $202.42 | -225 | 30.8K | -0.7% | -$45.5K | |
| D | 2023-06-02 | 2023-05-31 | STE | Steris | Zangerle John Adam | SVP, Gen Counsel, Sec | F - Tax | $199.97 | -249 | 27.6K | -0.9% | -$49.8K |
| D | 2023-06-02 | 2023-05-31 | STE | Steris | Zangerle John Adam | SVP, Gen Counsel, Sec | A - Grant | $0.00 | +3,471 | 31.1K | +13% | $0 |
| 2022-10-05 | 2022-10-03 | STE | Steris | Zangerle John Adam | SVP, Gen Counsel, Sec | F - Tax | $170.07 | -91 | 27.8K | -0.3% | -$15.5K | |
| 2022-06-17 | 2022-06-15 | STE | Steris | Zangerle John Adam | SVP, Gen Counsel, Sec | S - Sale | $205.31 | -2,659 | 27.9K | -9% | -$545.9K | |
| 2022-06-06 | 2022-06-02 | STE | Steris | Zangerle John Adam | SVP, Gen Counsel, Sec | F - Tax | $227.32 | -368 | 30.6K | -1% | -$83.7K | |
| D | 2022-06-03 | 2022-06-01 | STE | Steris | Zangerle John Adam | SVP, Gen Counsel, Sec | F - Tax | $221.46 | -675 | 27.6K | -2% | -$149.5K |
| D | 2022-06-03 | 2022-06-02 | STE | Steris | Zangerle John Adam | SVP, Gen Counsel, Sec | A - Grant | $0.00 | +3,384 | 31.0K | +12% | $0 |
| 2022-06-02 | 2022-05-31 | STE | Steris | Zangerle John Adam | SVP, Gen Counsel, Sec | F - Tax | $228.20 | -2,769 | 28.3K | -9% | -$631.9K | |
| D | 2022-04-21 | 2022-04-20 | STE | Steris | Zangerle John Adam | SVP, Gen Counsel, Sec | M - OptEx | $67.98 | +8,000 | 39.0K | +26% | +$543.8K |
| D | 2022-04-21 | 2022-04-20 | STE | Steris | Zangerle John Adam | SVP, Gen Counsel, Sec | S - Sale+OE | $255.48 | -8,000 | 31.0K | -21% | -$2.04M |
| D | 2021-10-05 | 2021-10-01 | STE | Steris | Zangerle John Adam | SVP, Gen Counsel, Sec | A - Grant | $0.00 | +808 | 31.0K | +3% | $0 |
Purchase Sale Sale after option exercise All abbreviations